SPCA2 Activators
SPCA2 activators encompass a diverse array of chemical compounds that indirectly promote the activity of SPCA2 by engaging with various cellular signaling cascades and modulating intracellular calcium dynamics. Forskolin, by boosting intracellular cAMP levels, indirectly facilitates the activation of protein kinase A (PKA), which may lead to the phosphorylation of proteins that regulate the calcium-transporting function of SPCA2, thereby enhancing its activity. The synthetic DAG analog, 1,2-Dioctanoyl-sn-glycerol (DiC8), activates protein kinase C (PKC) which can phosphorylate proteins associated with SPCA2, potentially augmenting its role in calcium ion transport. Ionomycin, as a calcium ionophore, escalates the intracellular calcium concentration, potentially necessitating increased SPCA2-mediated calcium transport to re-establish homeostasis. Furthermore, Calyculin A, by inhibiting protein phosphatases, maintains a phosphorylation state that could favor the activation of SPCA2's calcium transport function.
Continuing the theme of intracellular calcium modulation, Thapsigargin serves to disrupt calcium homeostasis by inhibiting the SERCA pump, thereby possibly amplifying the demand for SPCA2's calcium sequestering activity. Ryanodine and Phorbol 12-myristate 13-acetate (PMA) further facilitate the enhancement of SPCA2 through modulation of calcium channels and direct activation of PKC, respectively, both leading to a potential increase in SPCA2 activity. Anandamide and Nitrendipine, through their interaction with cannabinoid receptors and blockade of calcium channels, could create a cellular environment that requires the upregulation of SPCA2's transport capabilities. Finally, SKF-96365 and Nifedipine, by altering the usual calcium signaling pathways, could necessitate a compensatory increase in SPCA2's function, ensuring that calcium ion homeostasis is meticulously maintained. Collectively, these SPCA2 activators operate through distinct but complementary mechanisms, converging on the enhancement of SPCA2's essential role in calcium ion transport within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular levels of cAMP, which in turn activates PKA. Activated PKA can phosphorylate various proteins, potentially enhancing the function of SPCA2 by increasing its calcium-transporting activity. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
1,2-Dioctanoyl-sn-glycerol (DiC8) is a synthetic analog of diacylglycerol (DAG) that activates protein kinase C (PKC). PKC activation can lead to phosphorylation of proteins that may interact with or regulate SPCA2 activity, thus indirectly enhancing its function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which could indirectly stimulate SPCA2 activity to restore calcium homeostasis. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels within the cell. This could indirectly enhance SPCA2 activity by preventing dephosphorylation of proteins involved in calcium signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate is known to inhibit several protein kinases, potentially altering signaling pathways that could lead to an enhancement of SPCA2's role in calcium transport. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine binds to ryanodine receptors and modulates intracellular calcium release from the sarcoplasmic/endoplasmic reticulum. This modulation may increase the activity of SPCA2 as the cell attempts to regulate calcium levels. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of PKC, which can phosphorylate downstream targets that may include regulators of SPCA2, thereby enhancing its activity. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $109.00 $160.00 $458.00 | 6 | |
Nitrendipine is a calcium channel blocker that could lead to compensatory upregulation of intracellular calcium handling mechanisms, including the potential activation of SPCA2. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
SKF-96365 inhibits receptor-mediated calcium entry channels. The resulting alteration in calcium homeostasis could enhance SPCA2 function as the cell compensates for altered calcium influx. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is another calcium channel blocker that could indirectly increase SPCA2 activity by disrupting normal calcium signaling pathways, necessitating increased calcium transport by SPCA2. | ||||||